Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |